Related Experiment Video
Updated: Aug 27, 2025

08:05
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
156
Prediction of Adverse Pathology at Radical Prostatectomy in Grade Group 2 and 3 Prostate Biopsies Using Machine
Nathan Paulson1, Tal Zeevi2, Maria Papademetris2
1Stanford University, Stanford, CA.
JCO Clinical Cancer Informatics
|September 30, 2022
Summary
Machine learning accurately predicts adverse prostate cancer outcomes using biopsy images. This approach aids in estimating disease progression and informing treatment decisions for better patient care.
Area of Science:
- Computational pathology
- Digital pathology
- Machine learning in oncology
Background:
- Clinical need exists for improved prostate cancer outcome prediction.
- Machine learning (ML) offers a promising strategy for pathologic diagnosis and prognosis.
- Current methods require enhancement for predicting adverse outcomes.
Purpose of the Study:
- To develop and evaluate an ML algorithm for predicting adverse outcomes in prostate cancer.
- Utilize whole-slide images (WSIs) of prostate biopsies with Grade Group (GG) 2 or 3 disease.
- Assess ML algorithm performance against clinical risk assessment scores.
Main Methods:
- Retrospective review of prostate biopsies and corresponding radical prostatectomy (RP) data.
- Development of an ML pipeline involving image preprocessing, feature extraction (VGG-16), and classification (Extreme Gradient Boosting).
- Input data consisted of WSIs from hematoxylin and eosin-stained core needle biopsies.
Main Results:
- The ML model achieved an area under the receiver operating characteristic curve of 0.72 for the entire cohort.
- Performance varied by Grade Group: 0.65 for GG 2 and 0.89 for GG 3 patients.
- ML pipeline performance was comparable to the CAPRA clinical risk assessment score.
Conclusions:
- ML algorithms show potential in utilizing WSIs of prostate needle core biopsies.
- This approach can effectively estimate clinically relevant prostate cancer outcomes.
- WSIs combined with ML offer a novel tool for prostate cancer prognosis.

